Exane Derivatives’s Marvell Technology MRVL Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVL
Exane Derivatives's MRVL Position: Q1 2022 in Review
Exane Derivatives sold out of Marvell Technology (MRVL) in Q1 2022, closing a stake of 4,557 shares — an estimated $399K sold.
Exane Derivatives first reported a position in MRVL in Q2 2018 and held it in 8 quarters. The position peaked at $673K in Q3 2018. 913 funds tracked by Wall St. Rank hold MRVL as of Q1 2022.
- Exane Derivatives reported no remaining Marvell Technology position as of Q1 2022 after selling out during the quarter.
- Exane Derivatives sold 4,557 Marvell Technology shares in Q1 2022, an estimated $399K.
- Exane Derivatives first reported a position in Marvell Technology in Q2 2018 and held it in 8 quarters.
- Exane Derivatives's Marvell Technology position peaked at $673K in Q3 2018.
- 913 funds tracked by Wall St. Rank held Marvell Technology as of Q1 2022.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.